0001225208-19-011284.txt : 20190813
0001225208-19-011284.hdr.sgml : 20190813
20190813165444
ACCESSION NUMBER: 0001225208-19-011284
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190809
FILED AS OF DATE: 20190813
DATE AS OF CHANGE: 20190813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAHILL JOHN T
CENTRAL INDEX KEY: 0001197000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-00644
FILM NUMBER: 191021449
MAIL ADDRESS:
STREET 1: LEGG MASON, INC.
STREET 2: 100 INTERNATIONAL DRIVE
CITY: BALTIMORE
STATE: MD
ZIP: 21202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLGATE PALMOLIVE CO
CENTRAL INDEX KEY: 0000021665
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
IRS NUMBER: 131815595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 2123102000
MAIL ADDRESS:
STREET 1: 300 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
doc4.xml
X0306
4
2019-08-09
0000021665
COLGATE PALMOLIVE CO
CL
0001197000
CAHILL JOHN T
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
NEW YORK
NY
10022
1
Common Stock
2019-08-09
4
M
0
8000.0000
40.6000
A
30326.0000
D
Common Stock
2019-08-09
4
S
0
8000.0000
71.4309
D
22326.0000
D
Common Stock
23143.0000
I
By Trust
Stock Option (Right to Buy)
40.6000
2019-08-09
4
M
0
8000.0000
0.0000
D
2020-02-17
Common Stock
8000.0000
0.0000
D
Exercise of stock options awarded under the issuer's Non-Employee Director Stock Option Plan.
Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's Non-Employee Director Stock Option Plan.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $71.37 to $71.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
This amount includes 2,515 shares that were previously reported as directly beneficially owned.
Option became exercisable in one-third increments beginning on the first anniversary of the February 17, 2010 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact
2019-08-13